James Januzzi
Harvard University
H-index: 138
North America-United States
Top articles of James Januzzi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials | European Journal of Heart Failure | João Pedro Ferreira Javed Butler Stefan D Anker James L Januzzi Marina Panova‐Noeva | 2023/12/1 |
Physical Activity Levels And Cardiac Functional Capacity In Patients With Diabetic Cardiomyopathy: Baseline Analysis From The Arise-HF Trial | Journal of Cardiac Failure | Javed Butler Stefano Del Prato Justin Ezekowitz Nasrien Ibrahim Carolyn Lam | 2024/1/1 |
Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of … | European Heart Journal: Acute Cardiovascular Care | Júlia Karády Thomas Mayrhofer James L Januzzi James E Udelson Jerome L Fleg | 2024/1 |
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme | European Journal of Heart Failure | João Pedro Ferreira Milton Packer Naveed Sattar Javed Butler Stuart J Pocock | 2024/3/4 |
MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure | ESC Heart Failure | Aferdita Spahillari Laurel Jackson Dimitrios Varrias Sam A Michelhaugh James L Januzzi | 2024/2/6 |
THE ASSOCIATION OF IMMUNE-MEDIATED INFLAMMATORY DISEASE AND LIPOPROTEIN (A) WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG INDIVIDUALS WITH AND WITHOUT BASELINE … | Journal of the American College of Cardiology | Brittany Weber Adam N Berman Stephanie A Besser Daniel Huck Jon Mark Hainer | 2024/4/2 |
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction | Journal of the American College of Cardiology | Jacob A Udell Mark C Petrie W Schuyler Jones Stefan D Anker Josephine Harrington | 2024/4/6 |
Age-Related Usage of GLP-1 Agonists in Obese Patients With Heart Failure and Preserved Ejection Fraction | Journal of the American College of Cardiology | Aditya Achanta Lauren Belak Christine S Ritchie James L Januzzi Jason H Wasfy | 2024/4/9 |
Is Myocardial Infarction Overdiagnosed? | JAMA | Cian P McCarthy Jason H Wasfy James L Januzzi | 2024/4/24 |
Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data | Circulation: Cardiovascular Quality and Outcomes | Jason H Wasfy Mary Price Sharon-Lise T Normand James L Januzzi Jr Cian P McCarthy | 2024/1/19 |
Efficacy and safety of empagliflozin according to background diuretic use in HFrEF: post-hoc analysis of EMPEROR-Reduced | Heart Failure | Nitish K Dhingra Subodh Verma Javed Butler Stefan D Anker Joao Pedro Ferreira | 2024/1/1 |
NT-proBNP Concentrations in the Community: Elevation, Deficiency, and Everything in Between | Nasrien E Ibrahim James L Januzzi Jr | 2024/1/1 | |
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial | Cardiovascular Diabetology | James L Januzzi Stefano Del Prato Julio Rosenstock Javed Butler Justin Ezekowitz | 2024/2/1 |
Prognostic impact of repeated NT-proBNP measurements in patients with heart failure with reduced ejection fraction | Heart Failure | Michael A Fuery Eric S Leifer Marc D Samsky Sounok Sen Christopher M O’Connor | 2024/3/1 |
Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial | European Journal of Heart Failure | Naveed Sattar Javed Butler Matthew MY Lee Josephine Harrington Abhinav Sharma | 2024/4/1 |
Serum Urate Change Among Gout Patients Treated with Sodium-Glucose Cotransporter Type 2 Inhibitors vs. Sulfonylurea: A Comparative Effectiveness Analysis | Seminars in Arthritis and Rheumatism | Chio Yokose Greg Challener Bohang Jiang Baijun Zhou Natalie McCormick | 2024/4/5 |
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy | Journal of the American College of Cardiology | James L Januzzi Jr Javed Butler Stefano Del Prato Justin A Ezekowitz Nasrien E Ibrahim | 2024/4/8 |
Natriuretic Peptides and Prognosis in Patients with Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events | Journal of Cardiac Failure | Muhammad Shahzeb Khan James L Januzzi Jr Yuxi Liu Jialin Xu Wayne Shaw | 2024/4/16 |
Genetic Associations of Circulating Cardiovascular Proteins With Gestational Hypertension and Preeclampsia | JAMA cardiology | Art Schuermans Buu Truong Maddalena Ardissino Rohan Bhukar Eric AW Slob | 2024/1/3 |
Design of DISCOVER-HCM: A Registry of Real-world Treatment Patterns and Outcomes of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy | Journal of Cardiac Failure | Adrian Hernandez Frederick Masoudi Sula Mazimba Sara Saberi Soko Setoguchi | 2024/1/1 |
